Exact Sciences (EXAS) Q2 2022 Earnings Call Transcript
EXAS earnings call for the period ending June 30, 2022.
Stay updated with breaking news from Prostate Score. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
EXAS earnings call for the period ending June 30, 2022.
/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leader in advanced cancer diagnostics, today announced new data supporting its cancer tests and...
/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leader in advanced cancer diagnostics, today announced new data supporting its cancer tests and...
/PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), a leader in advanced cancer diagnostics, today announced that the company generated revenue of $473.8...
/PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company expects to report revenue between $472 million and $475 million for the...